Results
Corona Remedies Q1 Revenue Jumps 21.9% YoY
Corona Remedies reported Q1 FY27 revenue of ₹422 crore, a 21.9% YoY growth, significantly exceeding its 15% guidance.
EBITDA grew 33.5% to ₹93 crore with margins expanding 190 bps to 22%, while PAT in
